Calcutta HC Denies Abhishek Banerjee Immediate Relief in DJ Remark Voice Sample Case  ||  Bombay High Court Grants Bombay Group Relief in Vadilal Dispute Against Ahmedabad Group  ||  Kerala HC Orders Time-Bound Disposal of Prisoners' Remission Pleas, Mandates NALSA SOP Compliance  ||  Delhi HC Rejects Plea of Two Army Doctors Seeking NEET PG 2026 Exam Amid Eligibility Rule Challenge  ||  Jharkhand HC: Mother Cannot Consent to a Major Son's DNA Test During a Pending Matrimonial Case  ||  Bombay HC Rules on Whether Arrest is Illegal if Co-Accused Charge Sheet is Not Supplied Earlier  ||  Gujarat HC: State Cannot Indefinitely Reserve Private Land Without Acquisition or Plan Revision  ||  Chhattisgarh HC: Complaints Without Disciplinary Action Cannot Affect a Judge's Seniority  ||  Delhi HC Upholds Selection of India's Dressage Team For the 2026 Asian Games  ||  MP High Court Orders State to Airlift Gas Pipeline Blast Victim to Ahmedabad For Treatment    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved